NUS
Company Description
Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Track Record
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.49B | 1.73B | 1.97B | 2.23B | 2.70B | 2.58B | 2.42B | 2.68B | 2.28B | 2.21B | 2.25B | 2.57B |
| Net Income | 160.20M | (146.59M) | 8.60M | 104.78M | 147.27M | 191.35M | 173.55M | 121.89M | 129.44M | 143.09M | 133.05M | 189.18M |
| EPS | 3.25 | -2.95 | 0.17 | 2.10 | 2.93 | 3.66 | 3.13 | 2.21 | 2.45 | 2.58 | 2.29 | 3.20 |
| Free Cash Flow | 46.01M | 70.16M | 60.15M | 49.01M | 72.97M | 315.32M | 111.86M | 132.37M | 242.40M | 225.04M | N/A | N/A |
| FCF / Share | 0.93 | 1.41 | 1.21 | 0.98 | 1.45 | 6.03 | 2.01 | 2.40 | 4.59 | 4.06 | N/A | N/A |
| Operating CF | 80.29M | 111.74M | 118.64M | 108.06M | 141.58M | 379.14M | 177.93M | 202.74M | 302.56M | 275.26M | N/A | N/A |
| Total Assets | 1.41B | 1.47B | 1.81B | 1.82B | 1.91B | 1.96B | 1.77B | 1.69B | 1.59B | 1.47B | N/A | N/A |
| Total Debt | 364.25M | 478.23M | 607.33M | 520.52M | 503.79M | 500.38M | 507.01M | 430.46M | 388.63M | 416.89M | N/A | N/A |
| Cash & Equiv | 238.63M | 186.88M | 256.06M | 264.73M | 339.59M | 402.68M | 335.63M | 386.91M | 426.40M | 357.25M | N/A | N/A |
| Book Value | 805.24M | 651.46M | 821.97M | 897.30M | 912.77M | 894.27M | 875.29M | 781.87M | 704.60M | 664.07M | N/A | N/A |
| Return on Equity | 0.20 | -0.23 | 0.01 | 0.12 | 0.16 | 0.21 | 0.20 | 0.16 | 0.18 | 0.22 | N/A | N/A |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 320.61M | 370.32M | 364.21M | 386.14M | 364.49M | 445.55M | 430.14M | 439.08M | 417.31M | 488.64M | 498.77M | 500.26M |
| Net Income | 1.84M | 14.49M | 17.08M | 21.12M | 107.52M | (36.10M) | 8.30M | (118.26M) | (533,000) | 7.28M | (36.95M) | 26.89M |
| EPS | 0.04 | 0.30 | 0.35 | 0.43 | 2.16 | -0.73 | 0.17 | -2.38 | -0.01 | 0.15 | -0.74 | 0.54 |
| Free Cash Flow | (17.63M) | 5.86M | 17.57M | 35.78M | (13.20M) | 13.20M | 22.84M | 43.08M | (8.96M) | 33.78M | 39.12M | 20.81M |
| FCF / Share | -0.37 | 0.12 | 0.36 | 0.72 | -0.27 | 0.27 | 0.46 | 0.87 | -0.18 | 0.68 | 0.78 | 0.42 |
| Operating CF | (3.92M) | 16.62M | 27.48M | 35.80M | 389,000 | 25.79M | 31.43M | 51.21M | 3.32M | 54.17M | 51.03M | 35.52M |
| Total Assets | 1.38B | 1.41B | 1.42B | 1.44B | 1.39B | 1.47B | 1.58B | 1.59B | 1.74B | 1.81B | 1.79B | 1.89B |
| Total Debt | 277.61M | 364.25M | 291.43M | 310.74M | 300.71M | 478.23M | 501.82M | 528.64M | 557.38M | 607.33M | 571.10M | 582.24M |
| Cash & Equiv | 198.65M | 238.63M | 251.79M | 264.16M | 203.77M | 186.88M | 227.75M | 224.25M | 212.53M | 256.06M | 233.31M | 235.55M |
| Book Value | 794.09M | 805.24M | 799.79M | 787.75M | 753.97M | 651.46M | 706.88M | 686.16M | 810.21M | 821.97M | 822.19M | 895.35M |
| Return on Equity | 0.00 | 0.02 | 0.02 | 0.03 | 0.14 | -0.06 | 0.01 | -0.17 | -0.00 | 0.01 | -0.04 | 0.03 |
